Home > > > Report Detail

Global Recombinant Therapeutic Protein Market Research Report 2024

Publisher Name :
Date: 10-Jan-2024
No. of pages: 95
Inquire Before Buying

Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on The use of genetic recombination techniques to obtain recombinant vectors attached to gene fragments that can be translated into target proteins and then transferred to host cells that can express target proteins to express specific recombinant governance protein molecules.

The global Recombinant Therapeutic Protein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and The rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, The industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in The market and ensure their products reach patients in need. Additionally, The COVID-19 pandemic has highlighted The importance of vaccine development and supply chain management, further emphasizing The need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of The global market for Recombinant Therapeutic Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Recombinant Therapeutic Protein.

Report Scope

The Recombinant Therapeutic Protein market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Recombinant Therapeutic Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Recombinant Therapeutic Protein manufacturers, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Celldex Therapeutics

- Eli Liily

- GlaxoSmithKline

- Merck

- Novartis

- Regeneron Pharmaceuticals

- Roche

- Takeda

Segment by Type

- Recombinant Human Collage

- Recombinant Human Serum Albumin

Segment by Application

- Medicine

- Scientific Research

- Others

Consumption By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (

By Region, by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Detailed analysis of Recombinant Therapeutic Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Recombinant Therapeutic Protein in regional level and country level. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and market size of each country in The world.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including The upstream and downstream of The industry.

Chapter 8: Introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by manufacturers in The industry, and The analysis of relevant policies in The industry.

Chapter 9: The main points and conclusions of The report.

Global Recombinant Therapeutic Protein Market Research Report 2024

Table of Contents
1 Recombinant Therapeutic Protein Market Overview
1.1 Product Overview and Scope of Recombinant Therapeutic Protein
1.2 Recombinant Therapeutic Protein Segment by Type
1.2.1 Global Recombinant Therapeutic Protein Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Human Collage
1.2.3 Recombinant Human Serum Albumin
1.3 Recombinant Therapeutic Protein Segment by Application
1.3.1 Global Recombinant Therapeutic Protein Market Value by Application: (2024-2030)
1.3.2 Medicine
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Recombinant Therapeutic Protein Market Size Estimates and Forecasts
1.4.1 Global Recombinant Therapeutic Protein Revenue 2019-2030
1.4.2 Global Recombinant Therapeutic Protein Sales 2019-2030
1.4.3 Global Recombinant Therapeutic Protein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Therapeutic Protein Market Competition by Manufacturers
2.1 Global Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Therapeutic Protein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Therapeutic Protein Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Therapeutic Protein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Therapeutic Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Therapeutic Protein, Product Type & Application
2.7 Recombinant Therapeutic Protein Market Competitive Situation and Trends
2.7.1 Recombinant Therapeutic Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Therapeutic Protein Players Market Share by Revenue
2.7.3 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Therapeutic Protein Retrospective Market Scenario by Region
3.1 Global Recombinant Therapeutic Protein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Therapeutic Protein Global Recombinant Therapeutic Protein Sales by Region: 2019-2030
3.2.1 Global Recombinant Therapeutic Protein Sales by Region: 2019-2024
3.2.2 Global Recombinant Therapeutic Protein Sales by Region: 2025-2030
3.3 Global Recombinant Therapeutic Protein Global Recombinant Therapeutic Protein Revenue by Region: 2019-2030
3.3.1 Global Recombinant Therapeutic Protein Revenue by Region: 2019-2024
3.3.2 Global Recombinant Therapeutic Protein Revenue by Region: 2025-2030
3.4 North America Recombinant Therapeutic Protein Market Facts & Figures by Country
3.4.1 North America Recombinant Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Therapeutic Protein Sales by Country (2019-2030)
3.4.3 North America Recombinant Therapeutic Protein Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Therapeutic Protein Market Facts & Figures by Country
3.5.1 Europe Recombinant Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Therapeutic Protein Sales by Country (2019-2030)
3.5.3 Europe Recombinant Therapeutic Protein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Therapeutic Protein Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Therapeutic Protein Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Therapeutic Protein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Therapeutic Protein Market Facts & Figures by Country
3.7.1 Latin America Recombinant Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Therapeutic Protein Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Therapeutic Protein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Therapeutic Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Therapeutic Protein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Therapeutic Protein Sales by Type (2019-2030)
4.1.1 Global Recombinant Therapeutic Protein Sales by Type (2019-2024)
4.1.2 Global Recombinant Therapeutic Protein Sales by Type (2025-2030)
4.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Therapeutic Protein Revenue by Type (2019-2030)
4.2.1 Global Recombinant Therapeutic Protein Revenue by Type (2019-2024)
4.2.2 Global Recombinant Therapeutic Protein Revenue by Type (2025-2030)
4.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Therapeutic Protein Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Therapeutic Protein Sales by Application (2019-2030)
5.1.1 Global Recombinant Therapeutic Protein Sales by Application (2019-2024)
5.1.2 Global Recombinant Therapeutic Protein Sales by Application (2025-2030)
5.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Therapeutic Protein Revenue by Application (2019-2030)
5.2.1 Global Recombinant Therapeutic Protein Revenue by Application (2019-2024)
5.2.2 Global Recombinant Therapeutic Protein Revenue by Application (2025-2030)
5.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Therapeutic Protein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Celldex Therapeutics
6.3.1 Celldex Therapeutics Corporation Information
6.3.2 Celldex Therapeutics Description and Business Overview
6.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Product Portfolio
6.3.5 Celldex Therapeutics Recent Developments/Updates
6.4 Eli Liily
6.4.1 Eli Liily Corporation Information
6.4.2 Eli Liily Description and Business Overview
6.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Liily Recombinant Therapeutic Protein Product Portfolio
6.4.5 Eli Liily Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck Recombinant Therapeutic Protein Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Recombinant Therapeutic Protein Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Regeneron Pharmaceuticals
6.8.1 Regeneron Pharmaceuticals Corporation Information
6.8.2 Regeneron Pharmaceuticals Description and Business Overview
6.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Portfolio
6.8.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Recombinant Therapeutic Protein Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Corporation Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Takeda Recombinant Therapeutic Protein Product Portfolio
6.10.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Therapeutic Protein Industry Chain Analysis
7.2 Recombinant Therapeutic Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Therapeutic Protein Production Mode & Process
7.4 Recombinant Therapeutic Protein Sales and Marketing
7.4.1 Recombinant Therapeutic Protein Sales Channels
7.4.2 Recombinant Therapeutic Protein Distributors
7.5 Recombinant Therapeutic Protein Customers
8 Recombinant Therapeutic Protein Market Dynamics
8.1 Recombinant Therapeutic Protein Industry Trends
8.2 Recombinant Therapeutic Protein Market Drivers
8.3 Recombinant Therapeutic Protein Market Challenges
8.4 Recombinant Therapeutic Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Recombinant Therapeutic Protein Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Therapeutic Protein Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Therapeutic Protein Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Therapeutic Protein Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Therapeutic Protein Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Therapeutic Protein Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Therapeutic Protein, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Therapeutic Protein, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Therapeutic Protein, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Therapeutic Protein, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Therapeutic Protein as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Therapeutic Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Therapeutic Protein Sales by Region (2019-2024) & (MT)
Table 18. Global Recombinant Therapeutic Protein Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Therapeutic Protein Sales by Region (2025-2030) & (MT)
Table 20. Global Recombinant Therapeutic Protein Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Therapeutic Protein Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Therapeutic Protein Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Therapeutic Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Therapeutic Protein Sales by Country (2019-2024) & (MT)
Table 27. North America Recombinant Therapeutic Protein Sales by Country (2025-2030) & (MT)
Table 28. North America Recombinant Therapeutic Protein Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Therapeutic Protein Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Therapeutic Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Therapeutic Protein Sales by Country (2019-2024) & (MT)
Table 32. Europe Recombinant Therapeutic Protein Sales by Country (2025-2030) & (MT)
Table 33. Europe Recombinant Therapeutic Protein Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Therapeutic Protein Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Therapeutic Protein Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Therapeutic Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Therapeutic Protein Sales by Country (2019-2024) & (MT)
Table 42. Latin America Recombinant Therapeutic Protein Sales by Country (2025-2030) & (MT)
Table 43. Latin America Recombinant Therapeutic Protein Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Therapeutic Protein Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Therapeutic Protein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Therapeutic Protein Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Recombinant Therapeutic Protein Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Recombinant Therapeutic Protein Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Therapeutic Protein Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Therapeutic Protein Sales (MT) by Type (2019-2024)
Table 51. Global Recombinant Therapeutic Protein Sales (MT) by Type (2025-2030)
Table 52. Global Recombinant Therapeutic Protein Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Therapeutic Protein Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Therapeutic Protein Price (USD/MT) by Type (2019-2024)
Table 59. Global Recombinant Therapeutic Protein Price (USD/MT) by Type (2025-2030)
Table 60. Global Recombinant Therapeutic Protein Sales (MT) by Application (2019-2024)
Table 61. Global Recombinant Therapeutic Protein Sales (MT) by Application (2025-2030)
Table 62. Global Recombinant Therapeutic Protein Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Therapeutic Protein Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Therapeutic Protein Price (USD/MT) by Application (2019-2024)
Table 69. Global Recombinant Therapeutic Protein Price (USD/MT) by Application (2025-2030)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Recombinant Therapeutic Protein Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Business Overview
Table 77. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Bristol-Myers Squibb Recombinant Therapeutic Protein Product
Table 79. Bristol-Myers Squibb Recent Developments/Updates
Table 80. Celldex Therapeutics Corporation Information
Table 81. Celldex Therapeutics Description and Business Overview
Table 82. Celldex Therapeutics Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Celldex Therapeutics Recombinant Therapeutic Protein Product
Table 84. Celldex Therapeutics Recent Developments/Updates
Table 85. Eli Liily Corporation Information
Table 86. Eli Liily Description and Business Overview
Table 87. Eli Liily Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Eli Liily Recombinant Therapeutic Protein Product
Table 89. Eli Liily Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKline Recombinant Therapeutic Protein Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Merck Recombinant Therapeutic Protein Product
Table 99. Merck Recent Developments/Updates
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Novartis Recombinant Therapeutic Protein Product
Table 104. Novartis Recent Developments/Updates
Table 105. Regeneron Pharmaceuticals Corporation Information
Table 106. Regeneron Pharmaceuticals Description and Business Overview
Table 107. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product
Table 109. Regeneron Pharmaceuticals Recent Developments/Updates
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Roche Recombinant Therapeutic Protein Product
Table 114. Roche Recent Developments/Updates
Table 115. Takeda Corporation Information
Table 116. Takeda Description and Business Overview
Table 117. Takeda Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Takeda Recombinant Therapeutic Protein Product
Table 119. Takeda Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Recombinant Therapeutic Protein Distributors List
Table 123. Recombinant Therapeutic Protein Customers List
Table 124. Recombinant Therapeutic Protein Market Trends
Table 125. Recombinant Therapeutic Protein Market Drivers
Table 126. Recombinant Therapeutic Protein Market Challenges
Table 127. Recombinant Therapeutic Protein Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Therapeutic Protein
Figure 2. Global Recombinant Therapeutic Protein Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Therapeutic Protein Market Share by Type in 2023 & 2030
Figure 4. Recombinant Human Collage Product Picture
Figure 5. Recombinant Human Serum Albumin Product Picture
Figure 6. Global Recombinant Therapeutic Protein Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Therapeutic Protein Market Share by Application in 2023 & 2030
Figure 8. Medicine
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Global Recombinant Therapeutic Protein Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Therapeutic Protein Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Therapeutic Protein Sales (2019-2030) & (MT)
Figure 14. Global Recombinant Therapeutic Protein Average Price (USD/MT) & (2019-2030)
Figure 15. Recombinant Therapeutic Protein Report Years Considered
Figure 16. Recombinant Therapeutic Protein Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Therapeutic Protein Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Recombinant Therapeutic Protein Players: Market Share by Revenue in 2023
Figure 19. Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Therapeutic Protein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Therapeutic Protein Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Therapeutic Protein Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Therapeutic Protein Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Therapeutic Protein Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Recombinant Therapeutic Protein Sales Market Share by Country (2019-2030)
Figure 45. Latin America Recombinant Therapeutic Protein Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Recombinant Therapeutic Protein Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Recombinant Therapeutic Protein Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Recombinant Therapeutic Protein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Recombinant Therapeutic Protein by Type (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Therapeutic Protein by Type (2019-2030)
Figure 56. Global Recombinant Therapeutic Protein Price (USD/MT) by Type (2019-2030)
Figure 57. Global Sales Market Share of Recombinant Therapeutic Protein by Application (2019-2030)
Figure 58. Global Revenue Market Share of Recombinant Therapeutic Protein by Application (2019-2030)
Figure 59. Global Recombinant Therapeutic Protein Price (USD/MT) by Application (2019-2030)
Figure 60. Recombinant Therapeutic Protein Value Chain
Figure 61. Recombinant Therapeutic Protein Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs